Educational Activities

Show Filters
Hide Filters
1-4 of 4 Activities
Title
Availability
Format
Credits
Course Opens
Buttons
Live
Symposium
1
09/27/2025 at 12:00 PM EDT

Save the Date: MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

In this CEC Oncology live, case-based symposium, expert faculty will discuss key characteristics of clinical presentation and disease advancement over a lifespan; review patient and caregiver education needs on the integration of MEK inhibitors in the management of NF1-associated PNs; and explore the role of nurses in comprehensive care plans, including disease monitoring, treatment personalization, toxicity management, and transitioning care of patients with NF1 across their lifespan.

1
09/27/2025 at 12:00 PM EDT
Live
Symposium
1
09/27/2025 at 12:00 PM EDT

Save-the-Date: Livestream: MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

In this CEC Oncology livestream, case-based symposium, expert faculty will discuss key characteristics of clinical presentation and disease advancement over a lifespan; review patient and caregiver education needs on the integration of MEK inhibitors in the management of NF1-associated PNs; and explore the role of nurses in comprehensive care plans, including disease monitoring, treatment personalization, toxicity management, and transitioning care of patients with NF1 across their lifespan.

1
09/27/2025 at 12:00 PM EDT
Live
Grand Rounds
1
06/18/2025 at 12:00 PM EDT

Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team

Join our expert faculty for this 60-minute activity designed to help clinicians stay abreast of emerging trial data and evolving treatment guidelines, as well as effectively manage agent-specific AEs, to optimize care for their patients with mUC.

1
06/18/2025 at 12:00 PM EDT

Petros Grivas, MD, PhD

Petros Grivas, MD, PhD

Live
Webcast
1
06/25/2025 at 6:30 PM EDT

Emerging Considerations for the Role of Biomarker-Driven Immunotherapy in Upper GI Cancers

In this CE Concepts live webcast, expert faculty will discuss utilizing biomarker tests to select therapeutic approaches for patients with upper GI cancers, implementing current guidelines and recent clinical evidence to individualize treatment, and integrating an MDT approach to deliver high-quality disease management.

1
06/25/2025 at 6:30 PM EDT

Leslie Swanson, ARNP, AOCNP

Leslie Swanson, ARNP, AOCNP

Samuel J. Klempner, MD, FASCO

Samuel J. Klempner, MD, FASCO

Yelena Y. Janjigian, MD

Yelena Y. Janjigian, MD